2021-01-04,Akero Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-12,Is AKRO A Good Stock To Buy Now?
2020-11-24,Akero Therapeutics to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference
2020-11-13,Akero Presents Additional Positive Data from Phase 2a BALANCED Study Demonstrating Potential of Efruxifermin as a Foundational NASH Monotherapy
2020-11-12,Akero Therapeutics Reports Third Quarter 2020 Financial Results
2020-10-21,Akero Therapeutics To Present At Upcoming Conferences In November
2020-10-19,A Look Into Healthcare Sector Value Stocks
2020-10-16,Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
2020-10-02,Akero Therapeutics To Present Data From Phase 2a BALANCED Study Of Efruxifermin In NASH Patients In Presidential Plenary Talk At The Liver MeetingÂ® 2020
2020-09-30,Akero Therapeutics Completes Enrollment of Cohort of Cirrhotic (F4) Patients In Ongoing Balanced Study
2020-09-28,Akero Therapeutics to Present at H.C. Wainwright's 4th Annual NASH Virtual Investor Conference
2020-09-24,Akero Therapeutics To Continue Efruxifermin Development With Innovative Adaptive Phase 2b/3 Clinical Trial Design Based On FDA Written Guidance
2020-09-16,Morgan Stanley Bets on These 3 Stocks; Sees Over 40% Upside
2020-09-13,"Do Institutions Own Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares?"
2020-09-09,Akero Therapeutics To Present At Morgan Stanley's 18th Annual Global Healthcare Conference
2020-08-12,Akero Therapeutics Reports Second Quarter 2020 Financial Results
2020-07-23,A Top Contender in the Race for a NASH Drug Drops Out
2020-07-21,Research Published in Cell Reports Medicine Highlights Potential of Akero Therapeutics' NASH Therapeutic Candidate
2020-07-10,Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
2020-07-07,Akero Therapeutics Announces Pricing of Public Offering of Common Stock
2020-07-06,Akero Therapeutics Announces Proposed Public Offering of Common Stock
2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts"
2020-07-01,Akero Therapeutics (AKRO) Jumps: Stock Rises 8.9%
2020-07-01,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes"
2020-06-30,Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients
2020-06-29,Akero Therapeutics to Announce New Data from NASH Phase 2a BALANCED Study of AKR-001
2020-06-27,"Is Akero Therapeutics, Inc. (AKRO) A Good Stock To Buy?"
2020-06-17,Akero Therapeutics Doses First Patient in Expansion of Phase 2a Trial in NASH
2020-06-10,"Akero Therapeutics, Inc. (AKRO) Upgraded to Buy: Here's Why"
2020-06-10,Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?
2020-06-10,Moving Average Crossover Alert: Akero Therapeutics
2020-06-10,Akero Therapeutics Appoints Tom Heyman to its Board of Directors
2020-06-04,Could This Obscure Biotech Stock Make Early Investors a Fortune?
2020-05-27,Is Akero Therapeutics (AKRO) Stock a Solid Choice Right Now?
2020-05-26,Akero Therapeutics To Present At The Jefferies Virtual Healthcare Conference
2020-05-22,Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?
2020-05-13,Akero Therapeutics Reports First Quarter 2020 Financial Results
2020-05-08,Akero Therapeutics Inc (AKRO) Upgraded to Buy: Here's What You Should Know
2020-04-06,"What Makes Akero Therapeutics, Inc. (AKRO) a New Buy Stock"
2020-04-06,How Akero Therapeutics (AKRO) Stock Stands Out in a Strong Industry
2020-03-31,"The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions"
2020-03-31,All AKR-001 Dose Groups Met Week 12 Efficacy Endpoints in NASH Phase 2a BALANCED Study
2020-03-30,Akero Therapeutics to Announce Results for Week 12 Efficacy Endpoints from NASH Phase 2a BALANCED Study of AKR-001
2020-03-16,Should You Buy Akero Therapeutics (AKRO) Ahead of Earnings?
2020-03-16,Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-14,Canaccord: These 3 Stocks Are Poised to Surge by at Least 50%
2020-01-27,Quench Bio launches with $50M to treat 'missing link' to inflammatory disease
2020-01-13,Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients
2020-01-08,Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference
2019-12-19,4 More Biotechs With Blockbuster Potential
2019-12-16,Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH
2019-12-14,"Hedge Funds Are Dumping Akero Therapeutics, Inc. (AKRO)"
2019-11-13,Akero Therapeutics to Present at the Jefferies 2019 London Healthcare Conference
2019-11-12,Akero Therapeutics Reports Recent Highlights and Third Quarter 2019 Financial Results
2019-11-04,InSphero Wins Sino-European Innovation Award for Breakthrough NASH Discovery and Safety Testing Platform
2019-10-31,"Hedge Funds Have Never Been This Bullish On Akero Therapeutics, Inc. (AKRO)"
2019-09-19,"Does Akero Therapeutics, Inc. (NASDAQ:AKRO) Need To Raise More Cash?"
2019-09-04,Akero Therapeutics To Present At The Morgan Stanley 17th Annual Global Healthcare Conference
2019-08-12,Akero Therapeutics Reports Recent Highlights and Second Quarter 2019 Financial Results
2019-07-09,How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs
2019-07-03,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief"
2019-07-02,Akero Therapeutics Announces Dosing of First Patient in Phase 2a Study of AKR-001 to Treat NASH (BALANCED)
2019-06-24,Akero Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
2019-06-20,Akero Therapeutics IPO Opens Above IPO Price
2019-06-19,Akero Therapeutics Announces Pricing of Initial Public Offering
2019-06-18,Akero Therapeutics IPO: What You Need To Know
2019-06-17,IPO Outlook For The Week: Biotechs And A Grocery Outlet
